ranolazine has been researched along with Coronary Artery Stenosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheezum, MK; Di Carli, M; Evaristo, E; Foster, C; Hainer, J; Nearing, BD; Shah, NR; Stocco, FG; Verrier, RL | 1 |
| Borghesi, M; Ferlini, M; Musumeci, G | 1 |
| Crea, F; De Vita, A; Di Franco, A; Golino, M; Lamendola, P; Lanza, GA; Manfredonia, L; Melita, V; Mencarelli, E; Spera, FR; Villano, A | 1 |
| Astarita, C; Capuano, N; Caruso, A; Cirillo, T; Marinelli, U; Quaranta, G; Rigo, F; Romano, C; Tagliamonte, E | 1 |
| Cossarini, F; Kumthekar, A; Massera, D; Shih, JC; Taub, CC | 1 |
| Alexander, KP; Ben-Yehuda, O; Dressler, O; Farzaneh-Far, R; Généreux, P; Iñiguez, A; James, S; Ohman, EM; Osmukhina, A; Shechter, M; Stone, GW; Weisz, G; Zurakowski, A | 1 |
| Belardinelli, L; Datti, IP; Nanbu, DY; Nearing, BD; Nieminen, T; Pegler, JR; Tavares, CA; Vaz, GR; Verrier, RL | 1 |
| Dichtl, W; Sipötz, J | 1 |
5 trial(s) available for ranolazine and Coronary Artery Stenosis
| Article | Year |
|---|---|
Ranolazine reduces repolarization heterogeneity in symptomatic patients with diabetes and non-flow-limiting coronary artery stenosis.
Topics: Cardiovascular Agents; Coronary Stenosis; Cross-Over Studies; Diabetes Mellitus; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Ranolazine; Treatment Outcome | 2018 |
[The RIVER-PCI study].
Topics: Aged; Combined Modality Therapy; Coronary Stenosis; Double-Blind Method; Humans; Middle Aged; Percutaneous Coronary Intervention; Ranolazine; Sodium Channel Blockers | 2017 |
Microvascular ischemia in patients with successful percutaneous coronary intervention: effects of ranolazine and isosorbide-5-mononitrate.
Topics: Aged; Coronary Circulation; Coronary Stenosis; Coronary Vessels; Cross-Over Studies; Female; Humans; Isosorbide Dinitrate; Male; Microcirculation; Microvessels; Middle Aged; Percutaneous Coronary Intervention; Ranolazine; Rome; Single-Blind Method; Time Factors; Treatment Outcome; Vasodilator Agents | 2018 |
Effects of ranolazine on noninvasive coronary flow reserve in patients with myocardial ischemia but without obstructive coronary artery disease.
Topics: Cardiovascular Agents; Coronary Stenosis; Double-Blind Method; Echocardiography; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Myocardial Ischemia; Placebo Effect; Ranolazine; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2015 |
Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
Topics: Aged; Angina Pectoris; Coronary Artery Disease; Coronary Stenosis; Double-Blind Method; Female; Hospitalization; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Percutaneous Coronary Intervention; Ranolazine; Sodium Channel Blockers; Stroke | 2016 |
3 other study(ies) available for ranolazine and Coronary Artery Stenosis
| Article | Year |
|---|---|
Ranolazine-induced Repolarization Changes: A Case Report.
Topics: Acetanilides; Action Potentials; Chest Pain; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Electrocardiography; Female; Follow-Up Studies; Heart Conduction System; Humans; Long QT Syndrome; Middle Aged; Piperazines; Ranolazine; Risk Assessment; Sodium Channel Blockers; Stents; Takotsubo Cardiomyopathy | 2015 |
Antifibrillatory effect of ranolazine during severe coronary stenosis in the intact porcine model.
Topics: Acetanilides; Animals; Coronary Circulation; Coronary Stenosis; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Enzyme Inhibitors; Male; Piperazines; Ranolazine; Severity of Illness Index; Treatment Outcome; Ventricular Fibrillation | 2011 |
Radiation dermatitis.
Topics: Acetanilides; Aged; Coronary Angiography; Coronary Stenosis; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Male; Piperazines; Radiodermatitis; Ranolazine; Treatment Outcome | 2012 |